UPDATE: BPG’s CEO says ‘challenging economic headwinds’ aren't a major concern.
Listed pharma company signed exclusive licensing deal for intravenous form of its pain relief medicine in world’s second-largest pharma market.
‘We’re not denying this is probably one of the toughest retail environments that we can all remember,’ CEO says.
Restaurant group will also mop up smaller shareholders as it looks to beef up share price.
Infant formula marketer says acquisition talks unlikely to be behind share price surge.
Payment of 20c a kg available to suppliers still on board next May.
‘I don’t want to become an expert in this area, that’s for sure,’ CEO says about patent dispute.
Airline will not honour 1,800 bookings made following a currency conversion error on its South Korean website.
Chief executive Steve McCann, who took the job in June, says ASX-listed casino operator is ‘on its knees’.
Shares in the infant formula marketer were placed on trading halt amid a 15% price spike.